,CHEK1FBXO7

Tooba Razi1,2, Ally C Farrell1,2, Rubi Campos Gudiño1,2

  • 1Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, MB, Canada.

Molecular therapy. Oncology
|September 2, 2025
PubMed
概括

在结直肠癌 (CRC) 中FBXO7表达的减少与预后不佳相关. 针对CHEK1为患有FBXO7缺乏症的CRC患者提供了一种新的治疗策略,在临床前模型中显示出前景.